Form 4: CalciMedica Director Robert N. Wilson Acquires 54,000 Shares
SEC Form 4
Director Robert N. Wilson of CalciMedica, Inc. recently purchased 54,000 shares of common stock at an average price of $3.719 per share.
Summary
- On August 23, 2024, Robert N. Wilson, a director of CalciMedica, Inc. (CALC), acquired 54,000 shares of common stock.
- The purchase was made at a weighted average price of $3.719 per share, with individual prices ranging from $3.50 to $3.97.
- Following the transaction, Wilson directly owns 364,196 shares of CalciMedica common stock.
Sentiment
Score: 6
Explanation: Neutral sentiment. It's a routine transaction. The director's purchase is a mildly positive signal, but not significantly impactful on its own.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This purchase aligns with typical insider trading activity.
Stakeholder Impact
- The purchase could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/23/2024 | Date of the stock purchase transaction. |
| 08/26/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.